Nature Communications (Feb 2023)

Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants

  • Haisheng Yu,
  • Banghui Liu,
  • Yudi Zhang,
  • Xijie Gao,
  • Qian Wang,
  • Haitao Xiang,
  • Xiaofang Peng,
  • Caixia Xie,
  • Yaping Wang,
  • Peiyu Hu,
  • Jingrong Shi,
  • Quan Shi,
  • Pingqian Zheng,
  • Chengqian Feng,
  • Guofang Tang,
  • Xiaopan Liu,
  • Liliangzi Guo,
  • Xiumei Lin,
  • Jiaojiao Li,
  • Chuanyu Liu,
  • Yaling Huang,
  • Naibo Yang,
  • Qiuluan Chen,
  • Zimu Li,
  • Mengzhen Su,
  • Qihong Yan,
  • Rongjuan Pei,
  • Xinwen Chen,
  • Longqi Liu,
  • Fengyu Hu,
  • Dan Liang,
  • Bixia Ke,
  • Changwen Ke,
  • Feng Li,
  • Jun He,
  • Meiniang Wang,
  • Ling Chen,
  • Xiaoli Xiong,
  • Xiaoping Tang

DOI
https://doi.org/10.1038/s41467-023-36761-0
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 14

Abstract

Read online

In this study, authors identified neutralizing antibodies by isolating B cells from SARS-CoV-2 Delta infected patients and detect altered structural features, likely introduced by somatic hypermutation, that are involved in epitope binding and increase neutralization breadth against virus variants.